CONTACT
City of Hope
Zen Vuong
626-409-9367
George Smith Partners
Yang-Yang Guo
DUARTE, Calif. — City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, today announced that Zachary Streit, senior vice president at George Smith Partners Inc., a premier national provider of capital market services in commercial real estate, has been named president of City of Hope’s Los Angeles Real Estate & Construction Industries Council Building Hope board.
Streit has been a member of the Building Hope board for five years.
Founded in 2011, Building Hope aims to raise funds for and awareness of City of Hope’s lifesaving work and breakthrough scientific innovations in cancer care and research. Building Hope connects the passions and clout of the real estate industry’s rising stars in Los Angeles. The group has raised more than $800,000 toward critical funds for pediatric brain tumor clinical trials, to onboard new researchers at City of Hope, for blood drives and more.
“Zachary has jumped in with the type of enthusiasm and know-how we need to move into a post-2020 world,” said Diana Keim, vice president of annual philanthropy programs at City of Hope. “We’re extremely fortunate to have his leadership at the helm of Building Hope this year as we resume our important work supporting the leading-edge innovations at City of Hope that change lives.”
Streit has led the group in City of Hope’s successful speaker series, featuring Wayne Ratkovich of The Ratkovich Company. He will continue to be involved philanthropically within the community and will play an integral role in leading the board toward its mission and values.
As senior vice president at George Smith Partners, Streit works as part of a team that has closed $2.5 billion in debt and equity structured financings in the past three years. Streit is married to wife Skylar, and they have two children, Camden Jacob and Dylan Harrison, for whom he strives to make a better world.
City of Hope is one of only 52 National Cancer Institute (NCI)-designated comprehensive cancer centers in the U.S. The NCI designation recognizes excellence in treatment, research and expertise to address the many faces of the disease, whether in early or late stage, and for common or rare types of cancer.
# # #
About City of Hope
City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies, and numerous breakthrough cancer drugs are based on technology developed at the institution. Translational Genomics Research Institute (TGen) became a part of City of Hope in 2016. AccessHopeTM, a wholly owned subsidiary, was launched in 2019, dedicated to serving employers and their health care partners by providing access to City of Hope’s exceptional cancer expertise. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.